Example: Heart Attack

Clinical Trials on Dysentery, Amebic

Total 20 results

    • NCT02734264
      Completed
      Field Studies of Amebiasis in Bangladesh
      Conditions: Amebiasis; Cryptosporidium
    • NCT00366730
      Completed
      Study of Nitazoxanide in the Treatment of Amebiasis in Children
      Conditions: Amebiasis
    • NCT00366236
      Completed
      Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
      Conditions: Amebiasis
    • NCT02385058
      Completed
      Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
      Conditions: Helminthiasis; Amoebiasis
    • NCT02089048
      Completed
      Auranofin PK Following Oral Dose Administration
      Conditions: Amoebiasis
    • NCT02680665
      Completed
      Ameparomo Capsules 250 mg Drug Use Investigation
      Conditions: Intestinal Amebiasis
    • NCT02736968
      Recruiting
      Auranofin for Giardia Protozoa
      Conditions: Amoebic Dysentery; Giardiasis
    • NCT04759937
      Not yet recruiting
      Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.
      Conditions: Dysentery Amebic
    • NCT03491228
      Completed
      Anaemetro I.V. Infusion 500mg Drug Use Investigation
      Conditions: Anaerobic Infection; Infectious Enterocolitis; Amebic Dysentery
    • NCT03262025
      Completed
      Primary Cecal Pathologies Presenting as Acute Abdomen
      Conditions: Acute Abdomen; Emergency Surgery; Laparotomy; Amoebic Colitis; Diverticulitis of Caecum; Typhlitis
    • NCT00001162
      Terminated
      Parasitic Infections of the Gastrointestinal Tract
      Conditions: Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease; Gastrointestinal Helminth Infections
    • NCT02105714
      Completed
      Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
      Conditions: Soil-transmitted Helminthiasis; Schistosomiasis; Strongyloidiasis; Shigellosis; Intestinal Salmonellosis; Campylobacteriosis; Aeromonas Spp. Infections; Giardiasis; Amoebiasis; Dientamoebiasis; Cryptosporidium Spp. Infections
    • NCT01521403
      Active, not recruiting
      Is it Effective to Treat Patients With Blastocystis Hominis Infection?
      Conditions: Blastocystis Hominis Infections
    • NCT03484507
      Recruiting
      Parasitic Ulcer Treatment Trial Pilot
      Conditions: Acanthamoeba Keratitis
    • NCT03274895
      Active, not recruiting
      Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Subjects Affected by Acanthamoeba Keratitis
      Conditions: Acanthamoeba Keratitis
    • NCT02763605
      Unknown status
      Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years
      Conditions: Acanthamoeba Keratitis
    • NCT02506257
      Completed
      Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects
      Conditions: Acanthamoeba Keratitis
    • NCT03461978
      Enrolling by invitation
      Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
      Conditions: Meibomian Gland Dysfunction; Cataract; Glaucoma; Corneal Transplantation; Demodicosis; Conjunctival Pathologies; Acanthamoeba Keratitis; Aniridia
    • NCT01766830
      Completed
      Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
      Conditions: Visceral Leishmaniasis; Human African Trypanosomiasis; Enteric Fever; Melioidosis; Brucellosis; Leptospirosis; Relapsing Fever; Rickettsial Diseases; HIV; Tuberculosis; Malaria; Amoebic Liver Abscess
    • NCT00641992
      Completed
      Prognosis of Failure Treatment of Amebic Liver Abscess
      Conditions: Amebic Liver Abscess
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations